Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that members of ...
Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of ...
What: SETI Institute Artists-in-Residence present Exoplanetary Poetry, an art-science collaboration that trains artificial intelligence on exoplanet atmospheric chemi ...
Aging is associated with increased risk for nearly every lung disease, including acute conditions like pneumonia and chronic diseases like chronic obstructive pulmonary disease, idiopathic pulmonary ...
Those that solve artificially simplified problems where quantum advantage is meaningless. Those that provide no genuine quantum advantage when all costs are properly accounted for. This critique is ...
Early GO decision reached ahead of Q2’26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants ...
The partnership seeks to combine SMX's physical verification layer with LIQOS, by algo21's autonomous liquidity ...
Savvy developers are realizing the advantages of writing explicit, consistent, well-documented code that agents easily understand. Boring makes agents more reliable.
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...
This GEN eBook examines how ddPCR technology is applied in practice through case studies highlighting its analytical strengths over traditional qPCR.
Multiface analysis in action explores advanced methods for studying facial expressions in dyads, focus groups, and audience testing to uncover group emotions ...
LEGEND pivotal cohort update planned for a spring 2026 medical conference12-month complete response data from LEGEND pivotal cohort expected in 2H 2026Biologics License Application (BLA) submission ...